Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
109.01
+3.61 (3.43%)
At close: Dec 26, 2025
SHA:688578 Market Cap
SHA:688578 has a market cap or net worth of 49.05 billion as of December 26, 2025. Its market cap has increased by 81.44% in one year.
Market Cap
49.05B
Enterprise Value
45.78B
Revenue
4.76B
Ranking
n/a
PE Ratio
24.71
Stock Price
109.01
Market Cap Chart
Since December 2, 2020, SHA:688578's market cap has increased from 17.35B to 49.05B, an increase of 182.78%. That is a compound annual growth rate of 22.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 49.05B | 81.99% |
| Dec 31, 2024 | 26.96B | 43.78% |
| Dec 29, 2023 | 18.75B | 111.69% |
| Dec 30, 2022 | 8.86B | -34.83% |
| Dec 31, 2021 | 13.59B | 6.04% |
| Dec 31, 2020 | 12.82B | -26.12% |
| Dec 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 407.46B |
| WuXi AppTec | 271.20B |
| Shenzhen Mindray Bio-Medical Electronics | 241.87B |
| Sichuan Biokin Pharmaceutical | 136.66B |
| Shanghai United Imaging Healthcare | 106.29B |
| Aier Eye Hospital Group | 103.55B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.27B |